Organon & Co. (OGN)
13.79
+0.05
(+0.36%)
USD |
NYSE |
Oct 07, 16:00
13.78
-0.01
(-0.07%)
Pre-Market: 20:00
Organon Total Assets (Quarterly) : 13.18B for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.18B |
| March 31, 2026 | 13.00B |
| December 31, 2025 | 12.87B |
| September 30, 2025 | 13.55B |
| June 30, 2025 | 13.50B |
| March 31, 2025 | 13.16B |
| December 31, 2024 | 13.10B |
| September 30, 2024 | 12.75B |
| June 30, 2024 | 12.15B |
| March 31, 2024 | 11.89B |
| December 31, 2023 | 12.06B |
| September 30, 2023 | 11.01B |
| Date | Value |
|---|---|
| June 30, 2023 | 10.98B |
| March 31, 2023 | 10.76B |
| December 31, 2022 | 10.96B |
| September 30, 2022 | 10.44B |
| June 30, 2022 | 10.61B |
| March 31, 2022 | 10.60B |
| December 31, 2021 | 10.68B |
| September 30, 2021 | 11.34B |
| June 30, 2021 | 10.91B |
| March 31, 2021 | 9.642B |
| December 31, 2020 | 10.11B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 129.80B |
| Pfizer Inc. | 201.13B |
| Bristol Myers Squibb Co. | 87.63B |
| Harmony Biosciences Holdings, Inc. | 1.373B |
| ANI Pharmaceuticals, Inc. | 1.494B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.17B |
| Shareholders Equity (Quarterly) | 1.006B |
| Debt to Equity Ratio | 8.502 |
| Current Ratio | 1.954 |
| Net Debt Paydown Yield | 2.27% |